Login / Signup
Ferdinando Rossi
(Ferdinand Rossi)
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 3
Top Topics
Rna Seq
Epidermal Growth Factor Receptor
Poor Prognosis
Advanced Non Small Cell Lung Cancer
Top Venues
Cancer immunology research
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ferdinando Rossi
,
Mengyuan Liu
,
Andrew D Tieniber
,
Mark S Etherington
,
Andrew N Hanna
,
Gerardo A Vitiello
,
Nesteene J Param
,
Kevin J Do
,
Laura Wang
,
Cristina R Antonescu
,
Shan Zeng
,
Jennifer Q Zhang
,
Ronald P DeMatteo
Myosin light chain kinase inhibition potentiates the anti-tumor effects of avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Mark S Etherington
,
Andrew N Hanna
,
Benjamin D Medina
,
Mengyuan Liu
,
Andrew D Tieniber
,
Hyunjee V Kwak
,
Katherine J Tardy
,
Lillian Levin
,
Kevin J Do
,
Ferdinando Rossi
,
Shan Zeng
,
Ronald P DeMatteo
Tyrosine kinase inhibition activates intratumoral ϒδ T cells in gastrointestinal stromal tumor.
Cancer immunology research
(2023)
Andrew D Tieniber
,
Andrew N Hanna
,
Benjamin D Medina
,
Gerardo A Vitiello
,
Mark S Etherington
,
Mengyuan Liu
,
Kevin J Do
,
Ferdinando Rossi
,
Ronald P DeMatteo
Tyrosine Kinase Inhibition Alters Intratumoral CD8+ T-cell Subtype Composition and Activity.
Cancer immunology research
10 (10) (2022)